Jin10 data reported on April 14th that Haizheng Biological Materials announced the release of its 2024 annual report, stating that the company achieved an operating income of 845 million yuan, a year-on-year rise of 12.20%; net profit was 35.5046 million yuan, a year-on-year decrease of 18.47%; the net profit after deducting non-recurring gains and losses was 31.2289 million yuan, a year-on-year decrease of 22.54%. The company intends to distribute a cash dividend of 0.6 yuan (tax included) for every 10 shares.
View Original
This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
Haizheng Biological Materials: 2024 net profit of 35.5046 million yuan, a year-on-year decrease of 18.47%.
Jin10 data reported on April 14th that Haizheng Biological Materials announced the release of its 2024 annual report, stating that the company achieved an operating income of 845 million yuan, a year-on-year rise of 12.20%; net profit was 35.5046 million yuan, a year-on-year decrease of 18.47%; the net profit after deducting non-recurring gains and losses was 31.2289 million yuan, a year-on-year decrease of 22.54%. The company intends to distribute a cash dividend of 0.6 yuan (tax included) for every 10 shares.